Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01876641
Title Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib
Acronym ML28604
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of Iowa
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST